180 studies found for:    Open Studies | "Psoriasis"
Show Display Options
Rank Status Study
1 Unknown  Determination of Lymphocyte JAM-C Expression in Patients With Psoriasis Vulgaris
Conditions: Psoriasis;   Psoriasis Vulgaris
Intervention:
2 Recruiting A Study to Evaluate the Safety and Efficacy of Adalimumab in Subjects With Chronic Plaque Psoriasis and Nail Psoriasis
Conditions: Nail Psoriasis;   Plaque Psoriasis
Interventions: Biological: Adalimumab (ADA);   Other: Placebo
3 Unknown  A Study to Evaluate the Effectiveness of STELARA ™ (USTEKINUMAB) in the Treatment of Scalp Psoriasis
Conditions: Scalp Psoriasis;   Plaque Psoriasis
Interventions: Drug: Ustekinumab;   Drug: Placebo
4 Not yet recruiting TSO for Plaque Psoriasis
Condition: Plaque Psoriasis
Intervention: Biological: Trichuris Suis Ova
5 Recruiting Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients With Diabetes (DIP): A Randomized Clinical Trial.
Conditions: Psoriasis;   Type 2 Diabetes Mellitus
Interventions: Drug: Sitagliptin;   Drug: Gliclazide;   Drug: Sitagliptin matched placebo;   Drug: Gliclazide matched placebo capsule
6 Recruiting Vascular Inflammation in Psoriasis - Extension Study
Conditions: Psoriasis;   Cardiovascular Disease
Intervention: Drug: Adalimumab
7 Recruiting miRNAs and mRNAs in Psoriasis
Condition: Psoriasis
Intervention: Other: 4 mm punch biopsies
8 Not yet recruiting A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis
Condition: Psoriasis
Interventions: Drug: Guselkumab 100 mg;   Drug: Placebo for guselkumab;   Drug: Adalimumab;   Drug: Placebo for adalimumab
9 Recruiting A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis
Condition: Psoriasis
Intervention: Drug: CP-690,550
10 Recruiting A Study Evaluating The Efficacy And Safety oO CP-690,550 In Asian Subjects With Moderate To Severe Plaque Psoriasis
Condition: Psoriasis
Interventions: Drug: placebo;   Drug: CP-690,550
11 Recruiting A Study of Guselkumab in Participants With Moderate to Severe Plaque-type Psoriasis and an Inadequate Response to Ustekinumab
Condition: Psoriasis
Interventions: Drug: Ustekinumab;   Drug: Guselkumab;   Drug: Placebo for ustekinumab;   Drug: Placebo for guselkumab
12 Recruiting Spanish Registry of Systemic Treatments in Psoriasis
Condition: Psoriasis
Intervention:
13 Recruiting Vascular Inflammation in Psoriasis Trial (The VIP Trial)
Conditions: Psoriasis;   Cardiovascular Disease
Interventions: Drug: Adalimumab (Humira);   Drug: Placebo Injection;   Other: NB-UVB phototherapy
14 Unknown  Sensitivity and Specificity of QuantiFeron -TB Gold Test (QFT-G)in Patients With Psoriasis
Conditions: Tuberculosis;   Psoriasis
Intervention: Other: Tuberculin skin test and Quantiferon -TB Gold test
15 Recruiting Comparative Analysis of Small and Large Plaque Psoriasis
Condition: Psoriasis
Interventions: Procedure: Skin biopsy;   Procedure: Blood test
16 Recruiting Excimer Laser, Serum Markers & Psoriasis
Condition: Psoriasis
Intervention: Device: Excimer laser treatment
17 Not yet recruiting A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis With Randomized Withdrawal and Retreatment
Condition: Psoriasis
Interventions: Drug: Guselkumab 100 mg;   Drug: Placebo for guselkumab;   Drug: Adalimumab;   Drug: Placebo for adalimumab
18 Recruiting Monitoring and Modifying Atherosclerosis in Psoriasis Patients Study
Condition: Psoriasis
Intervention:
19 Recruiting PsoBest - The German Psoriasis Registry
Conditions: Psoriasis;   Psoriatic-arthritis
Intervention:
20 Recruiting Vascular Inflammation in Psoriasis-Ustekinumab (VIP-U)
Conditions: Psoriasis;   Cardiovascular Disease
Interventions: Drug: Ustekinumab;   Drug: Placebo

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years